Methicillin Resistance and Staphylococcus aureus in Nasal Cultures Before and During the Covid-19 Pandemic: A Comparison of the Results

Year 2022, Volume: 5 Issue: 1, 20 - 23, 01.04.2022

Mustafa Altıntaş , Murat Kar Gül Aydın Tığlı Yeşim Çekin

Abstract

Background: The COVID-19 pandemic remains a serious problem adversely affecting public health. The present study has been conducted in an attempt to evaluate the nasal carriage of Staphylococcus aureus before and during the pandemic.

Methods: In this study, the results of nasal cultures taken from patients who applied to our hospital for screening before and during the pandemic were retrospectively analyzed.

Results: In total, 2707 patients participated in the study. Out of these patients, 1602 were admitted to our hospital in 2019 and 1105 in 2020. According to the results of the study, the detection rates of Staphylococcus aureus were found to be 5.1% and 0.8% in 2019 and 2020, respectively. Such a decrease occurring during the time of the Covid-19 pandemic period was found to be statistically significant (χ2 = 36.61; P = .000). On the other hand, an increase was detected in the rate of methicillin-resistant Staphylococcus aureus during the pandemic. It was determined to be 17.3% in 2019 whereas it was 55.6% in 2020. This was found to be statistically significant (χ2 = 7.12; P = .008).

Conclusions: According to this study, there was a sharp decrease in Staphylococcus aureus carriage during the pandemic period compared to pre-pandemic, while methicillin-resistant Staphylococcus aureus rates increased more than 3 folds. This increase in methicillin-resistant Staphylococcus aureus rates may be due to the increasing trend of methicillin-resistant Staphylococcus aureus in recent years or may indicate that it depends on the measures associated with the pandemic. Further research in this area is essential.

Keywords

Covid-19 , nasal culture , methicillin resistance , pandemic , Staphylococcus aureus

References

• Mahmoudi H. Bacterial co-infections and antibiotic resistance in patientswith COVID-19. GMS Hyg Infect Control. 2020;15: ISSN 2196-5226.
• Tang YW, Stratton CW. Staphylococcus aureus: an old pathogen with new weapons. Clin Lab Med. 2010;30(1):179-208.
• Sollid JUE, Furberg AS, Hanssen AM, Johannessen M. Staphylococcus aureus: determinants of human carriage. Infect Genet Evol. 2014;21:531-541.
• Kluytmans-Vandenbergh MFQ, Kluytmans JAJW. Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clin Microbiol Infect. 2006;12(suppl 1):9-15.
• Emre A, Seyman D, Türker M, et al. Cases with skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Klimik Dergisi. 2020;33(2):180-184.
• Von Eıff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med. 2001;344(1):11-16.
• Alim A, Artan MO, Ataş M, Kalkan H, Madak S. Nasal carriage rate of staphylococcus auresus in individuals participating in the routine carrier inspection process in Sivas. Flora. 2012;17(4):202-205.
• Farrell JM, Zhao CY, Tarquinio KM, Brown SP. Causes and consequences of COVID-19 associated bacterial infections. Front Microbiol. 2021;12:(1-6).
• Adeiza SS, Shuaibu AB, Shuaibu GM. Random effects meta-analysis of COVID-19/S. aureus partnership in co-infection. GMS Hyg Infect Control. 2020;15: ISSN 2196-5226:Doc29.
• De Santis V, Corona A, Vitale D, Nencini C, Potalivo A, Prete A. Bacterial Infections in Critically ill Patients with SARS‑2‑COVID‑19 Infection: Results of a Prospective Observational Multicenter Study. Germany: Springer-Verlag GmbH, Part of Springer Nature; 2021.
• Baskaran V, Lawrence H, Lansbury LE, et al. Co-infection in critically ill patients with COVID-19: an observational cohort study from England.J Med Microbiol. 2021;70(4).
• Houlihan E, Hanahoe B, Vellinga A, Cormican M. Increase in community acquired S. aureus bloodstream infection associated with the Sars-Cov-2 public health emergency.Ir. Med J;114(3):305
• Sepin-Özen N, Tuğlu-Ataman Ş, Seyman D, Aldağ H, Emek M. investigation of nasal Staphylococcus aureus carriage and methicilin resistance rates with three different methods in food handlers working at Antalya. Turk Hij Den Biyol Derg. 2013;70(2):51-58.
• Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5(12):751-762.
• Acquisto NM, Bodkin RP, Brown JE,, et al. MRSA nares swab is a more accurate predictor of MRSA wound infection compared with clinical risk factors in emergency department patients with skin and soft tissue infections. Emerg Med J. 2018;35(6):357-360.
• Mainous AG 3rd, Hueston WJ, Everett CJ, Diaz VA. Nasal carriage of Staphylococcus aureus and methicillin-resistant S. aureus in the United States, 2001-2002. Ann Fam Med. 2006;4(2):132-137.
• Halablab MA, Hijazi SM, Fawzi MA, Araj GF. Staphylococcus aureus nasal carriage rate and associated risk factors in individuals in the community. Epidemiol Infect. 2010;138(5):702-706.
• Lu PL, Chin LC, Peng CF, et al. Risk factors and molecular analysis of community methicillin-resistant Staphylococcus aureus carriage. J Clin Microbiol. 2005;43(1):132-139.
• Hidron AI, Kourbatova EV, Halvosa JS, et al. Risk factors for colonization with methicillin-Resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis. 2005;41(2):159-166.
• Erdenizmenli M, Yapar N, Senger SS, Özdemir S, Yüce A. Investigation of colonization with methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population in Turkey. Jpn J Infect Dis. 2004;57(4):172-175.
• Kantarcıoğlu AS, Yücel A. Investigatıon of methicillin-resistant Staphylococcus aureus hand and nasal carriage among patientsí accomplices and visitors. Cerrahpaşa. J Med. 2002;33:97-103.
• Shopsin B, Mathema B, Martinez J, et al. Prevalence of methicillin-resistantand methicillin-susceptible Staphylococcus aureus in the community. J Infect Dis. 2000;182(1):359-362.
• Olsen SJ, Azziz-Baumgartner E, Budd AP, et al. Decreased Influenza Activity During the COVID-19 Pandemic United States, Australia, Chile and South Africa. US Dep Health Hum Serv/Centers Dis Control Prev MMWR. 2020;18(37):69.
• Alqahtani JS, Oyelade T, Aldhahir AM, et al. Reduction in hospitalised COPD exacerbations during COVID-19: a systematic review and meta-analysis. PLoS One. 2021;16(8):e0255659.